全科医生与风湿科医生对风湿性多肌痛现行管理实践的国际调查
该调查由六国风湿科医生与全科医生组成的工作组构建英文问卷,经国际PMR/巨细胞动脉炎研究组成员向全球全科医生与风湿科医生发放。共394名全科医生和937名风湿科医生回复,结果显示相当比例疑似PMR患者未被转诊、部分患者在风湿科评估前已开始泼尼松治疗,且56%的风湿科医生在招募PMR临床试验受试者时遇到困难。
要点
- 全科医生将疑似PMR患者转诊进行诊断的比例中位数为25%,其中50%被转回全科医生管理。
- 初始治疗中每日泼尼松>25 mg的比例为全科医生30%、风湿科医生12%。
- 56%的风湿科医生在招募PMR患者进入临床试验时遇到困难。
核心结论
- 这项大型国际调查表明,很大一部分PMR患者未被转诊进行诊断,且未经治疗患者的比例随转诊至评估时间延长而下降。
- 需要制定策略改变PMR患者的转诊与管理,以改善临床实践并促进临床试验招募。
研究设计与样本
- 由来自六国的风湿科医生与全科医生组成的工作组构建英文问卷,通过国际PMR/巨细胞动脉炎研究组成员向全球全科医生与风湿科医生发放。
- 问卷聚焦受访者特征、转诊实践、糖皮质激素治疗、诊断、合并症及研究障碍六方面。
- 共394名全科医生和937名风湿科医生回复调查。
主要发现
- 全科医生将疑似PMR患者转诊进行诊断的比例中位数为25%,其中50%被转回全科医生管理。
- 39%的风湿科医生在转诊后超过2周才评估疑似PMR患者,患者中位50%在风湿科医生评估前已开始泼尼松治疗。
- 初始治疗中每日泼尼松>25 mg的比例为全科医生30%、风湿科医生12%。
- 诊断影像很少使用。
- 56%的风湿科医生在招募PMR患者进入临床试验时遇到困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To explore current management practices for PMR by general practitioners (GPs) and rheumatologists including implications for clinical trial recruitment. METHODS: An English language questionnaire was constructed by a working group of rheumatologists and GPs from six countries. The questionnaire focused on: 1: Respondent characteristics; 2: Referral practices; 3: Treatment with glucocorticoids; 4: Diagnostics; 5: Comorbidities; and 6: Barriers to research. The questionnaire was distributed to rheumatologists and GPs worldwide via members of the International PMR/Giant Cell Arteritis Study Group. RESULTS: In total, 394 GPs and 937 rheumatologists responded to the survey. GPs referred a median of 25% of their suspected PMR patients for diagnosis and 50% of these were returned to their GP for management. In general, 39% of rheumatologists evaluated patients with suspected PMR >2 weeks after referral, and a median of 50% of patients had started prednisolone before rheumatologist evaluation. Direct comparison of initial treatment showed that the percentage prescribing >25 mg prednisolone daily for patients was 30% for GPs and 12% for rheumatologists. Diagnostic imaging was rarely used. More than half (56%) of rheumatologists experienced difficulties recruiting people with PMR to clinical trials. CONCLUSION: This large international survey indicates that a large proportion of people with PMR are not referred for diagnosis, and that the proportion of treatment-naive patients declined with increasing time from referral to assessment. Strategies are needed to change referral and management of people with PMR, to improve clinical practice and facilitate recruitment to clinical trials.
引用
- Donskov AO, Mackie SL, Hauge EM, et al. An international survey of current management practices for polymyalgia rheumatica by general practitioners and rheumatologists. Rheumatology (Oxford). 2023. PMID: 36637182. doi:10.1093/rheumatology/keac713
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。